title: TPMT testing in rheumatology: any better than routine monitoring?
authors.forename: K
authors.initials: K
authors.lastname: Payne
authors.forename: W
authors.initials: W
authors.lastname: Newman
authors.forename: E
authors.initials: E
authors.lastname: Fargher
authors.forename: K
authors.initials: K
authors.lastname: Tricker
authors.forename: I N
authors.initials: IN
authors.lastname: Bruce
authors.forename: W E R
authors.initials: WE
authors.lastname: Ollier
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D008780:Methyltransferases / Q000097:blood*; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine